Bispecific Antibodies Treat Cancer in Mouse Models
Bispecific Antibodies Treat Cancer in Mouse Models
A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.
Bispecific Antibodies Treat Cancer in Mouse Models
Bispecific Antibodies Treat Cancer in Mouse Models

A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.

A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.

B cells
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Ashley Yeager | Nov 23, 2020
Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Anthony King | Nov 11, 2020
Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 
Cracking Down on Cancer: A Profile of Owen Witte
Cracking Down on Cancer: A Profile of Owen Witte
Diana Kwon | Apr 1, 2020
Through his studies on cancer-causing viruses, the University of California, Los Angeles, professor has helped develop lifesaving treatments.
Gene Therapy Effective for Severe Combined Immunodeficiency
Gene Therapy Effective for Severe Combined Immunodeficiency
Shawna Williams | Apr 17, 2019
Researchers report they’ve found a way to restore immune function in infants with one form of “bubble boy disease.”
Culprit for Antibody Blockade Identified
Culprit for Antibody Blockade Identified
Amanda B. Keener | Oct 21, 2016
Type I interferon organizes several immune mechanisms to suppress B cell responses to a chronic viral infection.
Enhancing Vaccine Development
Enhancing Vaccine Development
Wudan Yan | Jun 1, 2016
Using proteomics methods to inform antigen selection
When the Flu Vax Fails
When the Flu Vax Fails
Jef Akst | Dec 16, 2015
The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study. 
B Cells Can Drive Inflammation in MS
B Cells Can Drive Inflammation in MS
Anna Azvolinsky | Oct 21, 2015
Researchers identify a subset of proinflammatory cytokine-producing B cells that may spark multiple sclerosis-related inflammation.  
Studying Ebola Survivors
Studying Ebola Survivors
Amanda B. Keener | Apr 6, 2015
A scientist jumps at the chance to study the blood of four Ebola survivors to better understand how the immune system responds to the deadly virus. 
Thanks for the Memories
Thanks for the Memories
Ruth Williams | Feb 1, 2015
B and T cells may be the memory masters of the immune system, but research reveals that other cells can be primed by pathogens, too.
Accelerating Antibody Discovery
Accelerating Antibody Discovery
Nicholette Zeliadt | May 1, 2014
Techniques for faster discovery and isolation of human monoclonal antibodies
Tumor-Targeting T Cells Engineered
Tumor-Targeting T Cells Engineered
Chris Palmer | Aug 11, 2013
Scientists genetically modify T cells derived from pluripotent stem cells to attack lymphatic tumors.
Biota Babble
Edyta Zielinska | Mar 1, 2012
Editor's choice in immunology
Beyond Expectation
Karen Hopkin | Sep 1, 2011
Philippa “Pippa” Marrack has made some unanticipated discoveries about how the immune system functions in health and disease.